Dr Jenny Miranda Campbell, MD | |
700 S 52nd St, Rogers, AR 72758-8605 | |
(479) 464-8887 | |
(479) 464-9949 |
Full Name | Dr Jenny Miranda Campbell |
---|---|
Gender | Female |
Speciality | Allergy/immunology |
Experience | 22 Years |
Location | 700 S 52nd St, Rogers, Arkansas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861607368 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 2006009443 (Missouri) | Secondary |
207K00000X | Allergy & Immunology | E-5372 (Arkansas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hedberg Allergy And Asthma Center Pa | 3476454026 | 5 |
Hedberg Allergy And Asthma Center Pa | 3476454026 | 5 |
News Archive
Nearly four years after passage of the health law, its major provisions finally took effect Jan. 1 and millions of Americans are about to see how it really works. Media outlets offer tip sheets to consumers and report on the challenges that lie ahead.
Blood transfusions can save the lives of patients who have suffered major blood loss, but hospitals don't always have enough or the right type on hand. In search of a solution, researchers have developed a promising substitute using blood's oxygen-carrying component, hemoglobin.
Janssen Research & Development, LLC announced today results of an open label, single-center, parallel group study showing that a type of medication called prothrombin complex concentrates can reverse the blood thinning effects of XARELTO (rivaroxaban) in healthy subjects.
In separate papers published online in Nature, two research teams report identifying a critical protein that Ebola virus exploits to cause deadly infections. The protein target is an essential element through which the virus enters living cells to cause disease.
› Verified 3 days ago
Entity Name | Hedberg Allergy And Asthma Center Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295820918 PECOS PAC ID: 3476454026 Enrollment ID: O20040116000205 |
News Archive
Nearly four years after passage of the health law, its major provisions finally took effect Jan. 1 and millions of Americans are about to see how it really works. Media outlets offer tip sheets to consumers and report on the challenges that lie ahead.
Blood transfusions can save the lives of patients who have suffered major blood loss, but hospitals don't always have enough or the right type on hand. In search of a solution, researchers have developed a promising substitute using blood's oxygen-carrying component, hemoglobin.
Janssen Research & Development, LLC announced today results of an open label, single-center, parallel group study showing that a type of medication called prothrombin complex concentrates can reverse the blood thinning effects of XARELTO (rivaroxaban) in healthy subjects.
In separate papers published online in Nature, two research teams report identifying a critical protein that Ebola virus exploits to cause deadly infections. The protein target is an essential element through which the virus enters living cells to cause disease.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jenny Miranda Campbell, MD 700 S 52nd St, Rogers, AR 72758-8605 Ph: (479) 464-8887 | Dr Jenny Miranda Campbell, MD 700 S 52nd St, Rogers, AR 72758-8605 Ph: (479) 464-8887 |
News Archive
Nearly four years after passage of the health law, its major provisions finally took effect Jan. 1 and millions of Americans are about to see how it really works. Media outlets offer tip sheets to consumers and report on the challenges that lie ahead.
Blood transfusions can save the lives of patients who have suffered major blood loss, but hospitals don't always have enough or the right type on hand. In search of a solution, researchers have developed a promising substitute using blood's oxygen-carrying component, hemoglobin.
Janssen Research & Development, LLC announced today results of an open label, single-center, parallel group study showing that a type of medication called prothrombin complex concentrates can reverse the blood thinning effects of XARELTO (rivaroxaban) in healthy subjects.
In separate papers published online in Nature, two research teams report identifying a critical protein that Ebola virus exploits to cause deadly infections. The protein target is an essential element through which the virus enters living cells to cause disease.
› Verified 3 days ago
Dr. Adesua Okupa Wejinya, B.S., M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 700 S 52nd St, Rogers, AR 72758 Phone: 479-464-8887 | |
Dr. Curtis Lars Hedberg, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 700 S 52nd St, Rogers, AR 72758 Phone: 479-464-8887 Fax: 479-464-9949 |